These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 211206)

  • 1. Schwann cell abnormalities in 2,5-hexanedione neuropathy.
    Powell HC; Koch T; Garrett R; Lampert PW
    J Neurocytol; 1978 Aug; 7(4):517-28. PubMed ID: 211206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Giant axonal neuropathy: a childhood disorder of microfilaments.
    Koch T; Schultz P; Williams R; Lampert P
    Ann Neurol; 1977 May; 1(5):438-51. PubMed ID: 214018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Schwann cell changes and demyelination in chronic galactose neuropathy.
    Powell HC; Myers RR
    Muscle Nerve; 1983; 6(3):218-27. PubMed ID: 6304510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental study on segmental demyelination in tellurium neuropathy.
    Takahashi T
    Hokkaido Igaku Zasshi; 1981 Mar; 56(2):105-31. PubMed ID: 6276282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An ultrastructural study of chronic cadmium chloride-induced neuropathy.
    Sato K; Iwamasa T; Tsuru T; Takeuchi T
    Acta Neuropathol; 1978 Mar; 41(3):185-90. PubMed ID: 206091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental lead neuropathy: a disease of the supporting cells in the peripheral nervous system.
    Schlaepfer WW
    J Neuropathol Exp Neurol; 1969 Jul; 28(3):401-18. PubMed ID: 4307024
    [No Abstract]   [Full Text] [Related]  

  • 7. Axonal degeneration in diphtheritic neuropathy.
    Bradley WG; Jennekens FG
    J Neurol Sci; 1971 Aug; 13(4):415-30. PubMed ID: 4328293
    [No Abstract]   [Full Text] [Related]  

  • 8. The response of the (myelinating) Schwann cell population to multiple episodes of demyelination.
    Hall SM
    J Neurocytol; 1983 Feb; 12(1):1-12. PubMed ID: 6302230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell body remodeling during dying-back axonopathy: DRG changes during advanced disease.
    Sterman AB
    J Neuropathol Exp Neurol; 1982 Jul; 41(4):400-11. PubMed ID: 6283036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gian axonal neuropathy--a generalized disorder of cytoplasmic microfilament formation.
    Prineas JW; Ouvrier RA; Wright RG; Walsh JC; McLeod JG
    J Neuropathol Exp Neurol; 1976 Jul; 35(4):458-70. PubMed ID: 180266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrastructural studies of the dying-back process. III. The evolution of experimental peripheral giant axonal degeneration.
    Spencer PS; Schaumburg HH
    J Neuropathol Exp Neurol; 1977; 36(2):276-99. PubMed ID: 190357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Supernumerary schwann cells during remyelination of regenerated and segmentally demyelinated axons in peripheral nerves].
    Schröder JM
    Verh Dtsch Ges Pathol; 1968; 52():222-8. PubMed ID: 4182232
    [No Abstract]   [Full Text] [Related]  

  • 13. Infantile chronic peripheral neuropathy with giant axons. Report of a case.
    Jedrzejowska H; Drac H
    Acta Neuropathol; 1977 Mar; 37(3):213-7. PubMed ID: 193342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrastructural studies of the dying-back process. V. Axonal neurofilaments accumulate at sites of 2,5-hexanedione application: evidence for nerve fibre dysfunction in experimental hexacarbon neuropathy.
    Politis MJ; Pellegrino RG; Spencer PS
    J Neurocytol; 1980 Aug; 9(4):505-16. PubMed ID: 7192310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental neuropathy produced by 2,5-hexanedione--a major metabolite of the neurotoxic industrial solvent methyl n-butyl ketone.
    Spencer PS; Schaumburg HH
    J Neurol Neurosurg Psychiatry; 1975 Aug; 38(8):771-5. PubMed ID: 171344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactive, degenerative, and proliferative Schwann cell responses in experimental galactose and human diabetic neuropathy.
    Kalichman MW; Powell HC; Mizisin AP
    Acta Neuropathol; 1998 Jan; 95(1):47-56. PubMed ID: 9452821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-stranded RNA induces iNOS gene expression in Schwann cells, sensory neuronal death, and peripheral nerve demyelination.
    Lee H; Park C; Cho IH; Kim HY; Jo EK; Lee S; Kho HS; Choi SY; Oh SB; Park K; Kim JS; Lee SJ
    Glia; 2007 May; 55(7):712-22. PubMed ID: 17348024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral neuropathy after exposure to methyl-isobutyl ketone in spray paint.
    AuBuchon J; Robins HI; Viseskul C
    Lancet; 1979 Aug; 2(8138):363-4. PubMed ID: 89425
    [No Abstract]   [Full Text] [Related]  

  • 19. Morphological study of peripheral nerve changes induced by chloroquine treatment.
    Tegnér R; Tomé FM; Godeau P; Lhermitte F; Fardeau M
    Acta Neuropathol; 1988; 75(3):253-60. PubMed ID: 2831692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Schwann cell degeneration induced by doxorubicin (adriamycin).
    England JD; Rhee EK; Said G; Sumner AJ
    Brain; 1988 Aug; 111 ( Pt 4)():901-13. PubMed ID: 2840999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.